Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ORL-1F in Leukocyte Adhesion Deficiency Type II
NCT03354533Phase 2Completed
- Sponsor
- Orpha Labs
- Start
- Jan 2012
- Primary completion
- Nov 2018
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of AUG-803 in leukocyte adhesion deficiency type II, sponsored by Orpha Labs. Started Jan 2012; status: completed.
02
Drugs
AUG-803
03
Conditions
leukocyte adhesion deficiency type II
Beyond the preview
Go deeper on NCT03354533.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03354533.